聞泰科技(600745.SH):目前產品集成新業務尚處於發展初期
格隆匯7月11日丨聞泰科技(600745.SH)近期舉行電話會議時表示, 經歷了 2020-2022 年的持續研發投入,公司已從手機 ODM 業務向產品集成業務轉型,在手機、平板 ODM 的基礎上,佈局了服務器、筆電、AIoT 產品、車載終端等領域,相關業務已經完成體系化成型的產品序列和型號的研發並逐步開始貢獻收入。目前產品集成新業務尚處於發展初期。2022 年產品集成業務營業收入為 395.69 億元,新產品佔比已逐步提升。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.